1

2
Keith Alec D, Snipes Wallace: Drug delivery device and method for its preparation.. Key Pharma, July 23, 1980: EP0013606-A2 (35 worldwide citation)

This invention provides a polymeric diffusion matrix comprising glycerol, polyvinylalcohol, a water-soluble polymer having hydration sites which in combination with the remaining ingredients yields a matrix capable of sustained release of a drug dispersed therein, and water. The matrix may further i ...


3
Keith Alec D Pennsylvania Stat, Snipes Wallace Pennsylvania St: Polymeric diffusion matrix and method of its preparation.. Key Pharma, December 2, 1981: EP0040861-A1 (19 worldwide citation)

This invention provides a polymeric diffusion matrix comprising glycerol, polyvinylalcohol, a water-soluble polymer having hydration sites which in combination with the remaining ingredients yields a matrix capable of sustained release of a drug dispersed therein, and water. The matrix may further i ...


4
Keith Alec D, Snipes Wallace: Burn matrix, method of its preparation and delivery device comprising said matrix.. Key Pharma, December 2, 1981: EP0040862-A1 (11 worldwide citation)

This invention provides a burn matrix comprising glycerol, polyvinylalcohol, a water-soluble polymer having hydration sites which in combination with the remaining ingredients yields a matrix capable of sustained release of a drug dispersed therein, and water. The matrix may further include a drug f ...


5
Keith Alec D: Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament.. Key Pharma, August 31, 1983: EP0087161-A2 (8 worldwide citation)

Herpes infections are treated with a mixture comprising a major amount of isopropylmyristate and a minor amount of a 4-(lower alkyl)-2,6-(bis-tert-butyl)-phenol, with 2,6-(bis-tert-butyl)-4-hydroxy-toluene being a preferred embodiment of the 4-(lower alkyl)-2,6-(bis-tert-butyl)-phenol.


6
Keith Alec D, Snipes Wallace: Matrice de diffusion polymerique, Polymeric diffusion matrix. Key Pharmaceuticals, KIRBY EADES GALE BAKER, November 16, 1982: CA1135625 (3 worldwide citation)

ABSTRACT OF THE DISCLOSURE This invention provides a polymeric diffusion matrixcomprising glycerol, polyvinylalcohol, a water soluble polymerhaving hydration sites which in combination with the remainingingredients yields a matrix capable of sustained release of adrug dispersed therein, and water. T ...


7
Hammerstedt Roy H, Keith Alec D, Amann Rupert P: Noningestible separation barrier with plugged pores.. Biopore, May 9, 1990: EP0367337-A1 (2 worldwide citation)

A noningestible separation barrier having one or more pores or micropores (of one or more diameters) therein, with the pores or micropores being initially plugged with one or more materials selected for its/their solubility and/or integrity characteristics relative to certain environmental condition ...


8
Keith Alec D, Snipes Wallace C: Buccal administration of estrogens.. Zetachron, October 12, 1988: EP0286581-A1 (1 worldwide citation)

An adequate blood plasma level of 17-beta-estradiol or ethinyl estradiol is attained in a patient in need of estrogen therapy by administration of a dose of 17-beta-estradiol or ethinyl estradiol or a pharmaceutically acceptable ester thereof not greater than 150 micrograms into the vestibule of the ...


9
Keith Alec D, Snipes Wallace: Polymeric diffusion matrix for administration of drugs. Key Pharma, January 15, 1982: FR2486397-A1 (1 worldwide citation)

MATRICE DE DIFFUSION POLYMERIQUE POUR LA LIBERATION CONTINUE D'AU MOINS UN MEDICAMENT SUR UNE PERIODE DE TEMPS PROLONGEE A UN PATIENT, SUSCEPTIBLE DE FOURNIR UN EFFET THERAPEUTIQUE PAR VOIE TRANSCUTANEE.ELLE COMPREND ENVIRON 2 A 60 EN POIDS D'UN ALCOOL POLYVINYLIQUE, ENVIRON 2 A 10 EN POIDS DE POLYV ...


10
Keith Alec D: Aspirin transdermal patch. Keith Alec D, JOHNSON Barbara E, September 15, 2005: WO/2005/084255 (1 worldwide citation)

An aspirin transdermal patch having an outer layer, a vapor impermeable layer, a vapor permeable layer, an aspirin containing layer, adhesive portions, and a peelable liner.